Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Longboard Pharmaceuticals Inc (NQ: LBPH ) 18.52 -1.43 (-7.17%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 460,317 Open 19.72 Bid (Size) 18.52 (6) Ask (Size) 18.56 (2) Prev. Close 19.95 Today's Range 18.00 - 19.98 52wk Range 3.600 - 28.15 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Longboard Pharmaceuticals Announces Positive Interim Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies (DEEs) June 10, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) June 03, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Performance YTD -26.22% -26.22% 1 Month -9.70% -9.70% 3 Month -9.57% -9.57% 6 Month +264.57% +264.57% 1 Year +121.53% +121.53% More News Read More Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) May 06, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Recap: Longboard Pharmaceuticals Q4 Earnings March 12, 2024 Via Benzinga LBPH Stock Earnings: Longboard Pharmaceuticals Beats EPS for Q1 2024 May 02, 2024 Via InvestorPlace Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates May 02, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15 April 03, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Looking Into Longboard Pharmaceuticals's Recent Short Interest January 19, 2024 Via Benzinga Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) April 02, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates March 12, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) March 01, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) February 02, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February February 01, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Forget the "Magnificent Seven" -- This Stock Has Nearly Quadrupled in 2024, and Wall Street Thinks It Can Go a Lot Higher January 17, 2024 Via The Motley Fool Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 26, 2024 Via Benzinga Cantor Fitzgerald Maintains Overweight Rating for Longboard Pharmaceuticals: Here's What You Need To Know January 16, 2024 Via Benzinga Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares January 08, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire This biotech stock has surged over 300% this week January 05, 2024 Via MarketBeat Jim Cramer: This Energy Firm Has 'Good Growth, Good Yield' But As For IonQ? Ixnay January 04, 2024 Via Benzinga Longboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock January 03, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Why Longboard Pharmaceuticals Stock Is Falling January 03, 2024 Via Benzinga Apple, Longboard Pharmaceuticals, Coinbase, Moderna, Tesla: Why These 5 Stocks Are On Investors' Radars Today January 02, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Longboard Pharma Catapulted 316%, Leading A Biotech Stock Rally January 02, 2024 Via Investor's Business Daily Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock January 02, 2024 From Longboard Pharmaceuticals, Inc. Via Business Wire Crude Oil Down 2%; Tesla Deliveries Top Estimates January 02, 2024 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
